EIF4A3 antibody
Principal name
EIF4A3 antibody
Alternative names for EIF4A3 antibody
DDX48, Eukaryotic initiation factor 4A-III, NMP265, Nuclear matrix protein 265, DEAD box protein 48, NUK34, KIAA0111, EIF4A-3, Eukaryotic translation initiation factor 4A isoform 3, ATP-dependent RNA helicase eIF4A-3, ATP-dependent RNA helicase DDX48
Ncbi ID
9606, NP_055555, NP_055555.1, NP_619610.1, NM_138669, NM_014740
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Paraffin Sections (P), Western blot / Immunoblot (WB)
Background of EIF4A3 antibody
- Kit Component:
- - KN305120G1, Eif4a3 gRNA vector 1 in pCas-Guide vector
- KN305120G2, Eif4a3 gRNA vector 2 in pCas-Guide vector
- KN305120D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Chan C.C., et al. (2004) RNA 10:200-209 Li Q, et al. (1999). Mol. Cell. Biol. 19 (11): 7336-46.




Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP302567 | EIF4A3 |
||||
| Recombinant protein of human eukaryotic translation initiation factor 4A, isoform 3 (EIF4A3) | |||||
![]() |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR206460L2V | Lenti ORF particles, Eif4a3 (GFP-tagged) - Mouse eukaryotic translation initiation factor 4A3 (Eif4a3), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| MR206460L1V | Lenti ORF particles, Eif4a3 (Myc-DDK-tagged) - Mouse eukaryotic translation initiation factor 4A3 (Eif4a3), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||





